APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Pain Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Pain Medicines Market Outlook and Growth Opportunities 2026

2 January 2026201 pages

Choose your research edition.

Industry ResearchOTC Pain Medicines Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Pain Medicines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal OTC Pain Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Pain Medicines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Pain Medicines Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global OTC Pain Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Pain Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Pain Medicines market include Zhejiang Kangle, Xinhua Pharmaceutical, Sanofi, Novartis, Pfizer, Hebei Jiheng, GlaxoSmithKline, Bayer and Anhui BBCA Likang, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Pain Medicines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Pain Medicines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Pain Medicines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Pain Medicines market.

OTC Pain Medicines Segment by Company

Zhejiang Kangle

Xinhua Pharmaceutical

Sanofi

Novartis

Pfizer

Hebei Jiheng

GlaxoSmithKline

Bayer

Anhui BBCA Likang

Strides Shasun

Sri Krishna Pharma

Seqens

Mallinckrodt

IOLCP

Granules India

Granules Biocause

Farmson

Anqiu Lu'an

OTC Pain Medicines Segment by Type

Naproxen

Acetaminophen

Ibuprofen

Aspirin

Others

OTC Pain Medicines Segment by Application

E-Commerce

Drug Stores

Hospital Pharmacies

OTC Pain Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Pain Medicines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Pain Medicines key companies, revenue, market share, and recent developments.

3. To split the OTC Pain Medicines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Pain Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Pain Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Pain Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Pain Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Pain Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Pain Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Pain Medicines industry.

Chapter 3: Detailed analysis of OTC Pain Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Pain Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Pain Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Pain Medicines Industry Trends Table 2. OTC Pain Medicines Industry Drivers Table 3. OTC Pain Medicines Industry Opportunities and Challenges Table 4. OTC Pain Medicines Industry Restraints Table 5. Global OTC Pain Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Pain Medicines Revenue Share by Company (2021-2026) Table 7. Global OTC Pain Medicines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Pain Medicines Key Company Manufacturing Base & Headquarters Table 9. Global OTC Pain Medicines Company, Product Type & Application Table 10. Global OTC Pain Medicines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Pain Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Naproxen Table 15. Significant Companies of Acetaminophen Table 16. Significant Companies of Ibuprofen Table 17. Significant Companies of Aspirin Table 18. Significant Companies of Others Table 19. Global OTC Pain Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global OTC Pain Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global OTC Pain Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global OTC Pain Medicines Sales Value Share by Type (2021-2026) Table 23. Global OTC Pain Medicines Sales Value Share by Type (2027-2032) Table 24. Significant Companies of E-Commerce Table 25. Significant Companies of Drug Stores Table 26. Significant Companies of Hospital Pharmacies Table 27. Global OTC Pain Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global OTC Pain Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global OTC Pain Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global OTC Pain Medicines Sales Value Share by Application (2021-2026) Table 31. Global OTC Pain Medicines Sales Value Share by Application (2027-2032) Table 32. Global OTC Pain Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global OTC Pain Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global OTC Pain Medicines Sales Value Share by Region (2021-2026) Table 35. Global OTC Pain Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global OTC Pain Medicines Sales Value Share by Region (2027-2032) Table 37. Global OTC Pain Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global OTC Pain Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global OTC Pain Medicines Sales Value Market Share by Country (2021-2026) Table 40. Global OTC Pain Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global OTC Pain Medicines Sales Value Market Share by Country (2027-2032) Table 42. Zhejiang Kangle Company Information Table 43. Zhejiang Kangle Business Overview Table 44. Zhejiang Kangle OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Zhejiang Kangle OTC Pain Medicines Product Portfolio Table 46. Zhejiang Kangle Recent Development Table 47. Xinhua Pharmaceutical Company Information Table 48. Xinhua Pharmaceutical Business Overview Table 49. Xinhua Pharmaceutical OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio Table 51. Xinhua Pharmaceutical Recent Development Table 52. Sanofi Company Information Table 53. Sanofi Business Overview Table 54. Sanofi OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Sanofi OTC Pain Medicines Product Portfolio Table 56. Sanofi Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Novartis OTC Pain Medicines Product Portfolio Table 61. Novartis Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Pfizer OTC Pain Medicines Product Portfolio Table 66. Pfizer Recent Development Table 67. Hebei Jiheng Company Information Table 68. Hebei Jiheng Business Overview Table 69. Hebei Jiheng OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hebei Jiheng OTC Pain Medicines Product Portfolio Table 71. Hebei Jiheng Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline OTC Pain Medicines Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bayer OTC Pain Medicines Product Portfolio Table 81. Bayer Recent Development Table 82. Anhui BBCA Likang Company Information Table 83. Anhui BBCA Likang Business Overview Table 84. Anhui BBCA Likang OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Anhui BBCA Likang OTC Pain Medicines Product Portfolio Table 86. Anhui BBCA Likang Recent Development Table 87. Strides Shasun Company Information Table 88. Strides Shasun Business Overview Table 89. Strides Shasun OTC Pain Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Strides Shasun OTC Pain Medicines Product Portfolio Table 91. Strides Shasun Recent Development Table 92. Sri Krishna Pharma Company Information Table 93. Sri Krishna Pharma Business Overview Table 94. Sri Krishna Pharma OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sri Krishna Pharma OTC Pain Medicines Product Portfolio Table 96. Sri Krishna Pharma Recent Development Table 97. Seqens Company Information Table 98. Seqens Business Overview Table 99. Seqens OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Seqens OTC Pain Medicines Product Portfolio Table 101. Seqens Recent Development Table 102. Mallinckrodt Company Information Table 103. Mallinckrodt Business Overview Table 104. Mallinckrodt OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mallinckrodt OTC Pain Medicines Product Portfolio Table 106. Mallinckrodt Recent Development Table 107. IOLCP Company Information Table 108. IOLCP Business Overview Table 109. IOLCP OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. IOLCP OTC Pain Medicines Product Portfolio Table 111. IOLCP Recent Development Table 112. Granules India Company Information Table 113. Granules India Business Overview Table 114. Granules India OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Granules India OTC Pain Medicines Product Portfolio Table 116. Granules India Recent Development Table 117. Granules Biocause Company Information Table 118. Granules Biocause Business Overview Table 119. Granules Biocause OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Granules Biocause OTC Pain Medicines Product Portfolio Table 121. Granules Biocause Recent Development Table 122. Farmson Company Information Table 123. Farmson Business Overview Table 124. Farmson OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Farmson OTC Pain Medicines Product Portfolio Table 126. Farmson Recent Development Table 127. Anqiu Lu'an Company Information Table 128. Anqiu Lu'an Business Overview Table 129. Anqiu Lu'an OTC Pain Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Anqiu Lu'an OTC Pain Medicines Product Portfolio Table 131. Anqiu Lu'an Recent Development Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. OTC Pain Medicines Product Image Figure 2. Global OTC Pain Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Pain Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Pain Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Naproxen Image Figure 8. Acetaminophen Image Figure 9. Ibuprofen Image Figure 10. Aspirin Image Figure 11. Others Image Figure 12. Global OTC Pain Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global OTC Pain Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global OTC Pain Medicines Sales Value Share by Type (2021-2032) Figure 15. E-Commerce Image Figure 16. Drug Stores Image Figure 17. Hospital Pharmacies Image Figure 18. Global OTC Pain Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Pain Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global OTC Pain Medicines Sales Value Share by Application (2021-2032) Figure 21. Global OTC Pain Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global OTC Pain Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America OTC Pain Medicines Sales Value (2021-2032) & (US$ Million) Figure 24. North America OTC Pain Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe OTC Pain Medicines Sales Value (2021-2032) & (US$ Million) Figure 26. Europe OTC Pain Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific OTC Pain Medicines Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific OTC Pain Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America OTC Pain Medicines Sales Value (2021-2032) & (US$ Million) Figure 30. South America OTC Pain Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa OTC Pain Medicines Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa OTC Pain Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt OTC Pain Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Acetaminophen
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • E-Commerce
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Zhejiang Kangle
  • Xinhua Pharmaceutical
  • Sanofi
  • Novartis
  • Pfizer
  • Hebei Jiheng
  • GlaxoSmithKline
  • Bayer
  • Anhui BBCA Likang
  • Strides Shasun
  • Sri Krishna Pharma
  • Seqens
  • Mallinckrodt
  • IOLCP
  • Granules India
  • Granules Biocause
  • Farmson
  • Anqiu Lu'an

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Pain Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Pain Medicines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Pain Medicines Market Dynamics
  1. 2.1 OTC Pain Medicines Industry Trends
  2. 2.2 OTC Pain Medicines Industry Drivers
  3. 2.3 OTC Pain Medicines Industry Opportunities and Challenges
  4. 2.4 OTC Pain Medicines Industry Restraints
3 OTC Pain Medicines Market by Company
  1. 3.1 Global OTC Pain Medicines Company Revenue Ranking in 2025
  2. 3.2 Global OTC Pain Medicines Revenue by Company (2021-2026)
  3. 3.3 Global OTC Pain Medicines Company Ranking (2024-2026)
  4. 3.4 Global OTC Pain Medicines Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Pain Medicines Company Product Type and Application
  6. 3.6 Global OTC Pain Medicines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Pain Medicines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Pain Medicines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Pain Medicines Market by Type
  1. 4.1 OTC Pain Medicines Type Introduction
  2. 4.1.1 Naproxen
  3. 4.1.2 Acetaminophen
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Aspirin
  6. 4.1.5 Others
  7. 4.2 Global OTC Pain Medicines Sales Value by Type
  8. 4.2.1 Global OTC Pain Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global OTC Pain Medicines Sales Value by Type (2021-2032)
  10. 4.2.3 Global OTC Pain Medicines Sales Value Share by Type (2021-2032)
5 OTC Pain Medicines Market by Application
  1. 5.1 OTC Pain Medicines Application Introduction
  2. 5.1.1 E-Commerce
  3. 5.1.2 Drug Stores
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global OTC Pain Medicines Sales Value by Application
  6. 5.2.1 Global OTC Pain Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Pain Medicines Sales Value by Application (2021-2032)
  8. 5.2.3 Global OTC Pain Medicines Sales Value Share by Application (2021-2032)
6 OTC Pain Medicines Regional Value Analysis
  1. 6.1 Global OTC Pain Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Pain Medicines Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Pain Medicines Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Pain Medicines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Pain Medicines Sales Value (2021-2032)
  7. 6.3.2 North America OTC Pain Medicines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Pain Medicines Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Pain Medicines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Pain Medicines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Pain Medicines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Pain Medicines Sales Value (2021-2032)
  16. 6.6.2 South America OTC Pain Medicines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Pain Medicines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Pain Medicines Sales Value Share by Country, 2025 VS 2032
7 OTC Pain Medicines Country-level Value Analysis
  1. 7.1 Global OTC Pain Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Pain Medicines Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Pain Medicines Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Pain Medicines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Pain Medicines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Pain Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Pain Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Kangle
  2. 8.1.1 Zhejiang Kangle Company Information
  3. 8.1.2 Zhejiang Kangle Business Overview
  4. 8.1.3 Zhejiang Kangle OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
  6. 8.1.5 Zhejiang Kangle Recent Developments
  7. 8.2 Xinhua Pharmaceutical
  8. 8.2.1 Xinhua Pharmaceutical Company Information
  9. 8.2.2 Xinhua Pharmaceutical Business Overview
  10. 8.2.3 Xinhua Pharmaceutical OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
  12. 8.2.5 Xinhua Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi OTC Pain Medicines Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis OTC Pain Medicines Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer OTC Pain Medicines Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Hebei Jiheng
  32. 8.6.1 Hebei Jiheng Company Information
  33. 8.6.2 Hebei Jiheng Business Overview
  34. 8.6.3 Hebei Jiheng OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
  36. 8.6.5 Hebei Jiheng Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer OTC Pain Medicines Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Anhui BBCA Likang
  50. 8.9.1 Anhui BBCA Likang Company Information
  51. 8.9.2 Anhui BBCA Likang Business Overview
  52. 8.9.3 Anhui BBCA Likang OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
  54. 8.9.5 Anhui BBCA Likang Recent Developments
  55. 8.10 Strides Shasun
  56. 8.10.1 Strides Shasun Company Information
  57. 8.10.2 Strides Shasun Business Overview
  58. 8.10.3 Strides Shasun OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Strides Shasun OTC Pain Medicines Product Portfolio
  60. 8.10.5 Strides Shasun Recent Developments
  61. 8.11 Sri Krishna Pharma
  62. 8.11.1 Sri Krishna Pharma Company Information
  63. 8.11.2 Sri Krishna Pharma Business Overview
  64. 8.11.3 Sri Krishna Pharma OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
  66. 8.11.5 Sri Krishna Pharma Recent Developments
  67. 8.12 Seqens
  68. 8.12.1 Seqens Company Information
  69. 8.12.2 Seqens Business Overview
  70. 8.12.3 Seqens OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Seqens OTC Pain Medicines Product Portfolio
  72. 8.12.5 Seqens Recent Developments
  73. 8.13 Mallinckrodt
  74. 8.13.1 Mallinckrodt Company Information
  75. 8.13.2 Mallinckrodt Business Overview
  76. 8.13.3 Mallinckrodt OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mallinckrodt OTC Pain Medicines Product Portfolio
  78. 8.13.5 Mallinckrodt Recent Developments
  79. 8.14 IOLCP
  80. 8.14.1 IOLCP Company Information
  81. 8.14.2 IOLCP Business Overview
  82. 8.14.3 IOLCP OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 IOLCP OTC Pain Medicines Product Portfolio
  84. 8.14.5 IOLCP Recent Developments
  85. 8.15 Granules India
  86. 8.15.1 Granules India Company Information
  87. 8.15.2 Granules India Business Overview
  88. 8.15.3 Granules India OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Granules India OTC Pain Medicines Product Portfolio
  90. 8.15.5 Granules India Recent Developments
  91. 8.16 Granules Biocause
  92. 8.16.1 Granules Biocause Company Information
  93. 8.16.2 Granules Biocause Business Overview
  94. 8.16.3 Granules Biocause OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Granules Biocause OTC Pain Medicines Product Portfolio
  96. 8.16.5 Granules Biocause Recent Developments
  97. 8.17 Farmson
  98. 8.17.1 Farmson Company Information
  99. 8.17.2 Farmson Business Overview
  100. 8.17.3 Farmson OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Farmson OTC Pain Medicines Product Portfolio
  102. 8.17.5 Farmson Recent Developments
  103. 8.18 Anqiu Lu'an
  104. 8.18.1 Anqiu Lu'an Company Information
  105. 8.18.2 Anqiu Lu'an Business Overview
  106. 8.18.3 Anqiu Lu'an OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
  108. 8.18.5 Anqiu Lu'an Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst